Antibacterial Therapies for Patients with an Unmet Medical Need for the Treatment of Serious Bacterial Diseases

Open Menu

HOME
SERVICES
WHO WE ARE
PARTNERSHIPS
RESOURCES
CAREER OPPORTUNITIES
CONTACT

You are here: Home > News > Antibacterial Therapies for Patients with an Unmet Medical Need for the Treatment of Serious Bacterial Diseases – Questions and Answers (Revision 1)

Antibacterial Therapies for Patients with an Unmet Medical Need for the Treatment of Serious Bacterial Diseases – Questions and Answers (Revision 1)

On 25 May 2022 the FDA published the draft Q&A guidance, revision 1. Comments may be submitted until 24 July 2022.

The purpose of this draft guidance is to assist sponsors in the clinical development of new antibacterial drugs and provide updates based on the availability of new therapeutic options for development programs.